A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B.

[1]  A. Lok,et al.  LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION , 1988, The Lancet.

[2]  M. Peters,et al.  Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial. , 1988, Annals of internal medicine.

[3]  Ching-lung Lai,et al.  PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDREN , 1987, The Lancet.

[4]  M. Tong,et al.  Persistence of serum hepatitis B virus deoxyribonucleic acid in hepatitis B surface antigen-positive patients with chronic persistent hepatitis treated with prednisone. , 1987, Gastroenterology.

[5]  J. Hoofnagle,et al.  A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial. , 2020, Annals of internal medicine.

[6]  M. Tong,et al.  A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B , 1986, Hepatology.

[7]  M. Tong,et al.  Prevention of maternal‐infant hepatitis B virus transmission by immunization: The role of serum hepatitis B virus DNA , 1986, Hepatology.

[8]  M. Tong,et al.  Effects of short-term, high-dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis. , 2008, Liver.

[9]  O. Yokosuka,et al.  Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study. , 1985, Gastroenterology.

[10]  R. Perrillo,et al.  Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B. , 1985, Gastroenterology.

[11]  J. Rakela,et al.  Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis. , 1983, Gastroenterology.

[12]  T. Merigan,et al.  Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. , 1981, Gastroenterology.

[13]  J. Hoofnagle,et al.  Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. , 1981, Annals of internal medicine.

[14]  C. Trépo,et al.  Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. , 1981, The New England journal of medicine.

[15]  M. Rugge,et al.  Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection , 1980 .

[16]  J. Boyer,et al.  Chronic hepatitis--a perspective on classification and determinants of prognosis. , 1976, Gastroenterology.